Related Experiment Video
Updated: Jan 7, 2026

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
Published on: March 24, 2017
Nanoflower-Shaped Peptide Assemblies Driven by Serrated β-Sheets and Hydrophobic Interactions for High-Affinity MUC1
Bokai Ma1,2, Jinge Zhao1,3, Shuang Li2
1Key Laboratory of Medical Molecule Science and Pharmaceutics Engineering, Ministry of Industry and Information Technology, Key Laboratory of Cluster Science of Ministry of Education, Beijing Key Laboratory of Photo-Electronic/Electro-Photonic Conversion Materials, School of Chemistry and Chemical Engineering, Institute of Engineering Medicine, Beijing Institute of Technology, Beijing 100081, PR China.
None:
The transmembrane glycoprotein mucin 1 (MUC1), a glycosylated transmembrane protein, is a clinically valuable tumor marker in various malignant tumors. However, the high fluidity of the cell membrane and the heterogeneity of carbohydrate chain pose difficulties for efficient and stable recognition. Peptide assemblies show significant advantages in target recognition, with enhanced stability and affinity. Herein, we designed a three-motif peptide to take into account both MUC1 targeting and peptide assembly. A peptide library comprising over 108 candidates was synthesized based on "one-bead-one-compound" combinatorial chemistry strategy, and the MUC1-targeted peptide (KLF) was screened with a dissociation constant of ∼10-8 mol/L. Further mechanism studies revealed that KLF bound to the nonglycosylated dimerization interface of the MUC1 heterodimer. Driven by hydrophobic and β-sheet interactions, KLF self-assembled into flower-shaped nanostructures with the targeting motif exposed on the surface, which showed high affinity and selectivity for MUC1 recognition in various tumor cells. Finally, a drug delivery system based on the KLF assembly was designed and proved effective in tumor therapy in mouse models. This work provides insights into the rational design of peptide assembly systems for targeted recognition and disease therapy.

